CorpAcq Holdings Limited entered into an agreement to acquire Churchill Capital Corp VII (NYSE:CVII) in a reverse merger transaction on August 1, 2023. CorpAcq Founder and Chairman Simon Orange will continue to lead the combine company, along with Chief Executive Officer David Martin and the rest of CorpAcq?s seasoned leadership team. Upon closing of the transaction, the combined company will operate as CorpAcq and intends to list on the New York Stock Exchange. The transaction has been approved by the Boards of Directors of CorpAcq and Churchill VII. The transaction is subject to approval by Churchill VII?s shareholders. The transaction is expected to close in late 2023 or early 2024.

Citigroup Global Markets Inc. acted as financial advisor to Churchill VII. Duff & Phelps acted as fairness opinion to the board of directors of Churchill VII. Jennifer W. Cheng, Chris Sheaffer, Susan Nieto and Daryl Cue of Reed Smith LLP acted as legal advisor to CorpAcq. Michael J. Aiello, Matthew Gilroy and Amanda Fenster of Weil, Gotshal & Manges LLP acted as legal advisor to Churchill VII.